John L Higgins - Net Worth and Insider Trading
John L Higgins Net Worth
The estimated net worth of John L Higgins is at least $49 Million dollars as of 2024-06-08. John L Higgins is the Director of Ligand Pharmaceuticals Inc and owns about 422,984 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $34 Million. John L Higgins is the Director of OmniAb Inc and owns about 2,462,686 shares of OmniAb Inc (OABI) stock worth over $11 Million. John L Higgins is also the Director of Bio-Techne Corp and owns about 36,608 shares of Bio-Techne Corp (TECH) stock worth over $3 Million. Details can be seen in John L Higgins's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John L Higgins has not made any transactions after 2024-05-14 and currently still holds the listed stock(s).
Transaction Summary of John L Higgins
John L Higgins Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John L Higgins owns 5 companies in total, including Ligand Pharmaceuticals Inc (LGND) , Bio-Techne Corp (TECH) , and BioCryst Pharmaceuticals Inc (BCRX) among others .
Click here to see the complete history of John L Higgins’s form 4 insider trades.
Insider Ownership Summary of John L Higgins
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
LGND | Ligand Pharmaceuticals Inc | 2022-12-16 | CEO & President |
TECH | Bio-Techne Corp | 2024-05-14 | director |
BCRX | BioCryst Pharmaceuticals Inc | 2005-05-11 | director |
2022-11-01 | director | ||
2023-05-23 | director |
John L Higgins Latest Holdings Summary
John L Higgins currently owns a total of 3 stocks. Among these stocks, John L Higgins owns 422,984 shares of Ligand Pharmaceuticals Inc (LGND) as of December 16, 2022, with a value of $34 Million and a weighting of 70.69%. John L Higgins owns 2,462,686 shares of OmniAb Inc (OABI) as of May 23, 2023, with a value of $11 Million and a weighting of 23.47%. John L Higgins also owns 36,608 shares of Bio-Techne Corp (TECH) as of May 14, 2024, with a value of $3 Million and a weighting of 5.84%.
Latest Holdings of John L Higgins
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
LGND | Ligand Pharmaceuticals Inc | 2022-12-16 | 422,984 | 81.36 | 34,413,978 |
OABI | OmniAb Inc | 2023-05-23 | 2,462,686 | 4.64 | 11,426,863 |
TECH | Bio-Techne Corp | 2024-05-14 | 36,608 | 77.63 | 2,841,879 |
Holding Weightings of John L Higgins
John L Higgins Form 4 Trading Tracker
According to the SEC Form 4 filings, John L Higgins has made a total of 8 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years, including 1 buys and 7 sells. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 10,000 shares on December 16, 2022, which brought John L Higgins around $618,700.
According to the SEC Form 4 filings, John L Higgins has made a total of 3 transactions in OmniAb Inc (OABI) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in OmniAb Inc is the sale of 9,000 shares on May 23, 2023, which brought John L Higgins around $36,450.
According to the SEC Form 4 filings, John L Higgins has made a total of 5 transactions in Bio-Techne Corp (TECH) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Bio-Techne Corp is the sale of 4,000 shares on May 14, 2024, which brought John L Higgins around $335,360.
Insider Trading History of John L Higgins
- 1
John L Higgins Trading Performance
GuruFocus tracks the stock performance after each of John L Higgins's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John L Higgins is 3.88%. GuruFocus also compares John L Higgins's trading performance to market benchmark return within the same time period. The performance of stocks bought by John L Higgins within 3 months outperforms 4 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John L Higgins's insider trading performs compared to the benchmark.
Performance of John L Higgins
John L Higgins Ownership Network
Ownership Network List of John L Higgins
Ownership Network Relation of John L Higgins
John L Higgins Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
John L Higgins is the CEO & President of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include Chief Financial Officer Octavio Espinoza , VP & Finance and CFO Matthew E Korenberg , and CHIEF LEGAL OFFICER & Andrew Reardon .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, John L Higgins made 1 insider transaction in Ligand Pharmaceuticals Inc (LGND) with a net sale of 10,000. Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 13,433 shares made by Octavio Espinoza , a net sale of 10,852 shares made by John W Kozarich , and a net sale of 10,300 shares made by Andrew Reardon .
In summary, during the past 3 months, insiders sold 41,825 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 41,825 shares. During the past 18 months, 71,418 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 67,418 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
John L Higgins Mailing Address
Above is the net worth, insider trading, and ownership report for John L Higgins. You might contact John L Higgins via mailing address: 11119 North Torrey Pines Road, Suite 200, La Jolla Ca 92037.